State Street
HARP

State Street’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

State Street’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,523
Closed -$60.5K – 4666
2023
Q2 		$60.5K Hold
8,523
– – ﹤0.01% 4373
2023
Q1 		$63.4K Hold
8,523
– – ﹤0.01% 4444
2022
Q4 		$61.9K Hold
8,523
– – ﹤0.01% 4508
2022
Q3 		$83K Sell
8,523
-470
-5% -$8.77K ﹤0.01% 4529
2022
Q2 		$172K Sell
8,993
-35,334
-80% -$915K ﹤0.01% 4278
2022
Q1 		$2.2M Buy
44,327
+5,891
+15% +$305K ﹤0.01% 3528
2021
Q4 		$2.9M Buy
38,436
+64
+0.2% +$4.37K ﹤0.01% 3504
2021
Q3 		$3.03M Sell
38,372
-94,465
-71% -$9.5M ﹤0.01% 3492
2021
Q2 		$18.4M Buy
132,837
+112,370
+549% +$21.4M ﹤0.01% 2566
2021
Q1 		$4.28M Buy
20,467
+3,364
+20% +$674K ﹤0.01% 3114
2020
Q4 		$2.84M Sell
17,103
-589
-3% -$91K ﹤0.01% 3223
2020
Q3 		$3.01M Buy
17,692
+804
+5% +$116K ﹤0.01% 3035
2020
Q2 		$2.8M Buy
16,888
+2,327
+16% +$363K ﹤0.01% 3046
2020
Q1 		$1.69M Buy
14,561
+2,172
+18% +$305K ﹤0.01% 3126
2019
Q4 		$1.83M Buy
12,389
+1,666
+16% +$253K ﹤0.01% 3280
2019
Q3 		$1.47M Buy
10,723
+2,407
+29% +$338K ﹤0.01% 3316
2019
Q2 		$1.08M Buy
+8,316
New +$966K ﹤0.01% 3408

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street's HARP Position: Q3 2023 in Review

State Street sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 8,523 shares — an estimated $60.5K sold.

State Street first reported a position in HARP in Q2 2019 and held it in 17 quarters. The position peaked at $18.4M in Q2 2021. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • State Street reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • State Street sold 8,523 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $60.5K.
  • State Street first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 17 quarters.
  • State Street's Harpoon Therapeutics, Inc. Common Stock position peaked at $18.4M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.